skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: Journals@Ovid Complete remover Base de dados/Biblioteca: Publisher website remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Spatial mapping of mitochondrial networks and bioenergetics in lung cancer
Spatial mapping of mitochondrial networks and bioenergetics in lung cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Spatial mapping of mitochondrial networks and bioenergetics in lung cancer

Han, Mingqi ; Bushong, Eric A ; Segawa, Mayuko ; Tiard, Alexandre ; Wong, Alex ; Brady, Morgan R ; Momcilovic, Milica ; Wolf, Dane M ; Zhang, Ralph ; Petcherski, Anton ; Madany, Matthew ; Xu, Shili ; Lee, Jason T ; Poyurovsky, Masha V ; Olszewski, Kellen ; Holloway, Travis ; Gomez, Adrian ; John, Maie St ; Dubinett, Steven M ; Koehler, Carla M ; Shirihai, Orian S ; Stiles, Linsey ; Lisberg, Aaron ; Soatto, Stefano ; Sadeghi, Saman ; Ellisman, Mark H ; Shackelford, David B

Nature (London), 2023-03, Vol.615 (7953), p.712-719 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
2
Risk of rupture of unruptured cerebral aneurysms in elderly patients
Risk of rupture of unruptured cerebral aneurysms in elderly patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Risk of rupture of unruptured cerebral aneurysms in elderly patients

Hishikawa, Tomohito ; Date, Isao ; Tokunaga, Koji ; Tominari, Shinjiro ; Nozaki, Kazuhiko ; Shiokawa, Yoshiaki ; Houkin, Kiyohiro ; Murayama, Yuichi ; Ishibashi, Toshihiro ; Takao, Hiroyuki ; Kimura, Toshikazu ; Nakayama, Takeo ; Morita, Akio

Neurology, 2015-11, Vol.85 (21), p.1879-1885 [Periódico revisado por pares]

United States: American Academy of Neurology

Texto completo disponível

Citações Citado por
3
EGFR ligands and ERCC1 mRNA expression to predict clinical outcome in Japanese (JPN) patients (pts) with metastatic colorectal cancer (mCRC) harboring overexpressed EGFR and KRAS exon 2 wild-type ( KRAS wt) treated with cetuximab (cet) plus oxaliplatin-based chemotherapy (JACCRO CC-05/06 AR)
EGFR ligands and ERCC1 mRNA expression to predict clinical outcome in Japanese (JPN) patients (pts) with metastatic colorectal cancer (mCRC) harboring overexpressed EGFR and KRAS exon 2 wild-type ( KRAS wt) treated with cetuximab (cet) plus oxaliplatin-based chemotherapy (JACCRO CC-05/06 AR)
Material Type:
Artigo 		Adicionar ao Meu Espaço

EGFR ligands and ERCC1 mRNA expression to predict clinical outcome in Japanese (JPN) patients (pts) with metastatic colorectal cancer (mCRC) harboring overexpressed EGFR and KRAS exon 2 wild-type ( KRAS wt) treated with cetuximab (cet) plus oxaliplatin-based chemotherapy (JACCRO CC-05/06 AR)

Sunakawa, Yu ; Ichikawa, Wataru ; Tsuji, Akihito ; Moran, Miriana ; Astrow, Stephanie H. ; Yang, Dongyun ; Zhang, Wu ; Takahashi, Takehiro ; Denda, Tadamichi ; Shimada, Ken ; Kochi, Mitsugu ; Nakamura, Masato ; Kotaka, Masahito ; Segawa, Yoshihiko ; Takeuchi, Masahiro ; Lenz, Heinz-Josef ; Fujii, Masashi ; Nakajima, Toshifusa

Journal of clinical oncology, 2015-01, Vol.33 (3_suppl), p.618-618 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
4
The Natural Course of Unruptured Cerebral Aneurysms in a Japanese Cohort
The Natural Course of Unruptured Cerebral Aneurysms in a Japanese Cohort
Material Type:
Artigo 		Adicionar ao Meu Espaço

The Natural Course of Unruptured Cerebral Aneurysms in a Japanese Cohort

Morita, Akio ; Kirino, Takaaki ; Hashi, Kazuo ; Aoki, Noriaki ; Fukuhara, Shunichi ; Hashimoto, Nobuo ; Nakayama, Takeo ; Sakai, Michi ; Teramoto, Akira ; Tominari, Shinjiro ; Yoshimoto, Takashi

The New England journal of medicine, 2012-06, Vol.366 (26), p.2474-2482 [Periódico revisado por pares]

Waltham, MA: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
5
Impacts of T and N factors on curability of pancreatic, gastric, and colonic cancers
Impacts of T and N factors on curability of pancreatic, gastric, and colonic cancers
Material Type:
Artigo 		Adicionar ao Meu Espaço

Impacts of T and N factors on curability of pancreatic, gastric, and colonic cancers

Maetani, S. ; Segawa, Y. ; Banja, H. ; Obayashi, H. ; Imamura, M. ; Gamel, J. W.

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e21042-e21042 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
6
A randomized phase III study of cisplatin and docetaxel with or without irinotecan in pts with advanced non-small cell lung cancer: Okayama Lung Cancer Study Group OLCSG 0403
A randomized phase III study of cisplatin and docetaxel with or without irinotecan in pts with advanced non-small cell lung cancer: Okayama Lung Cancer Study Group OLCSG 0403
Material Type:
Artigo 		Adicionar ao Meu Espaço

A randomized phase III study of cisplatin and docetaxel with or without irinotecan in pts with advanced non-small cell lung cancer: Okayama Lung Cancer Study Group OLCSG 0403

Kiura, K. ; Tabata, M. ; Takigawa, N. ; Kuyama, S. ; Segawa, Y. ; Kamei, H. ; Shibayama, T. ; Hotta, K. ; Matsuo, K. ; Tanimoto, M.

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.7584-7584 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
7
A randomized phase II study of a combination of docetaxel and S-1 versus docetaxel monotherapy in pts with NSCLC previously treated with platinum-based chemotherapy: Results of Okayama Lung Cancer Study Group (OLCSG) trial 0503
A randomized phase II study of a combination of docetaxel and S-1 versus docetaxel monotherapy in pts with NSCLC previously treated with platinum-based chemotherapy: Results of Okayama Lung Cancer Study Group (OLCSG) trial 0503
Material Type:
Artigo 		Adicionar ao Meu Espaço

A randomized phase II study of a combination of docetaxel and S-1 versus docetaxel monotherapy in pts with NSCLC previously treated with platinum-based chemotherapy: Results of Okayama Lung Cancer Study Group (OLCSG) trial 0503

Segawa, Y. ; Hotta, K. ; Takigawa, N. ; Matsuo, K. ; Yoshioka, H. ; Hayashi, H. ; Nogami, N. ; Tabata, M. ; Kiura, K. ; Tanimoto, M.

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.8058-8058 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
8
Randomized phase III trial of docetaxel and cisplatin combination chemotherapy versus mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiation therapy for locally advanced non-small-cell lung cancer: OLCSG 0007
Randomized phase III trial of docetaxel and cisplatin combination chemotherapy versus mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiation therapy for locally advanced non-small-cell lung cancer: OLCSG 0007
Material Type:
Artigo 		Adicionar ao Meu Espaço

Randomized phase III trial of docetaxel and cisplatin combination chemotherapy versus mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiation therapy for locally advanced non-small-cell lung cancer: OLCSG 0007

Kiura, K. ; Takigawa, N. ; Segawa, Y. ; Kamei, H. ; Takemoto, M. ; Tabata, M. ; Ueoka, H. ; Hiraki, S. ; Matsuo, K. ; Tanimoto, M.

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.7515-7515 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
9
A phase II trial of combination chemotherapy with irinotecan and amrubicin in pretreated patients with non-small cell lung cancer
A phase II trial of combination chemotherapy with irinotecan and amrubicin in pretreated patients with non-small cell lung cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase II trial of combination chemotherapy with irinotecan and amrubicin in pretreated patients with non-small cell lung cancer

Segawa, Y. ; Nogami, N. ; Shinkai, T. ; Kiura, K. ; Tabata, M. ; Takigawa, N. ; Hotta, K. ; Shibayama, T. ; Ueoka, H. ; Tanimoto, M.

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.18111-18111 [Periódico revisado por pares]

Sem texto completo

Citações Citado por
10
Clinical factors affecting the late resistance to gefitinib in patients with non-small cell lung cancer (NSCLC)
Clinical factors affecting the late resistance to gefitinib in patients with non-small cell lung cancer (NSCLC)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical factors affecting the late resistance to gefitinib in patients with non-small cell lung cancer (NSCLC)

Segawa, Y. ; Hotta, K. ; Umemura, S. ; Fujiwara, Y. ; Shinkai, T. ; Ueoka, H. ; Takigawa, N. ; Tabata, M. ; Kiura, K. ; Tanimoto, M.

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.7191-7191 [Periódico revisado por pares]

Sem texto completo

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (52)
  2. Revistas revisadas por pares (78)

Data de Publicação 

De até
Refinar
  1. Antes de1987  (7)
  2. 1987Até1993  (13)
  3. 1994Até1999  (23)
  4. 2000Até2006  (29)
  5. Após 2006  (9)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.